Literature DB >> 21962260

Intraoperative oncologic staging and outcomes for lung cancer resection vary by surgeon specialty.

Michelle C Ellis1, Brian S Diggs, John T Vetto, Paul H Schipper.   

Abstract

BACKGROUND: In the United States the majority of lung cancer resections are performed by general surgeons, although surgeons specializing in thoracic surgery have demonstrated superior perioperative and long-term oncologic outcomes. Why these differences exist has not been well studied. We hypothesized that the completeness of intraoperative oncologic staging may explain some of these differences.
METHODS: The Nationwide Inpatient Sample (NIS) database was used to review 222,233 patients with primary lung cancer treated surgically with wedge resection, segmentectomy, lobectomy, or pneumonectomy from 1998 to 2007. Surgeons were classified as general thoracic surgeons if they performed greater than 75% general thoracic operations and less than 10% cardiac operations; they were classified as cardiac surgeons if they performed greater than 10% cardiac operations; they were classified as general surgeons if they performed less than 75% thoracic operations and less than 10% cardiac operations. The main outcome measure was the performance of lymphadenectomy or mediastinoscopy during the same admission as the cancer resection.
RESULTS: The overall lymphadenectomy rate was 56% (n = 125,115) and was highest for general thoracic surgeons at 73% (n = 13,313), followed by 55% (n = 65,453) for general surgeons, and 54% (n = 46,349) for cardiac surgeons (p < 0.0001). General surgeons had a significantly higher risk for in-hospital mortality (odds ratio [OR], 1.47; confidence interval [CI], 1.14 to 1.90; p = 0.003) and postoperative complications (OR, 1.17; CI, 1.00 to 1.36; p = 0.043) compared with general thoracic surgeons.
CONCLUSIONS: Surgeon specialty impacts the adequacy of oncologic staging in patients undergoing resection for primary lung cancer. Specifically, general thoracic surgeons performed intraoperative oncologic staging significantly more often than did their general surgeon and cardiac surgeon counterparts while achieving significantly lower in-hospital mortality and complication rates.
Copyright © 2011 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21962260     DOI: 10.1016/j.athoracsur.2011.05.120

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  11 in total

1.  VATS lobectomy lymph node management.

Authors:  Gavin M Wright
Journal:  Ann Cardiothorac Surg       Date:  2012-05

2.  Minimally invasive thoracic surgery in lung cancer: respecting oncologic principles is the key.

Authors:  Diego Gonzalez-Rivas; William Guido-Guerrero; Albert Bolaños-Cubillo
Journal:  Ann Transl Med       Date:  2018-12

3.  Lymph node assessment and survival: we still have work to do.

Authors:  Timothy Tirrell; Mark Onaitis
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

4.  Effects of Positive Mental Nursing on the Post-Traumatic Growth, Negative Emotions, and Coping Style of Patients after Chemotherapy for Leukemia.

Authors:  Feng Wei; Qin Li
Journal:  Iran J Public Health       Date:  2022-04       Impact factor: 1.479

5.  Social determinants and facility type impact adherence to best practices in operable IIIAN2 lung cancer.

Authors:  Zaid Muslim; Stephanie Stroever; Mirza Zain Baig; Joanna F Weber; Cliff P Connery; Faiz Y Bhora
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-08-19

6.  Multidisciplinary Treatment for Stage IIIA Non-Small Cell Lung Cancer: Does Institution Type Matter?

Authors:  Pamela Samson; Aalok Patel; Traves D Crabtree; Daniel Morgensztern; Cliff G Robinson; Graham A Colditz; Saiama Waqar; Daniel Kreisel; A Sasha Krupnick; G Alexander Patterson; Stephen Broderick; Bryan F Meyers; Varun Puri
Journal:  Ann Thorac Surg       Date:  2015-07-28       Impact factor: 4.330

Review 7.  Lung cancer surgery: an up to date.

Authors:  Nikolaos Baltayiannis; Michail Chandrinos; Dimitrios Anagnostopoulos; Paul Zarogoulidis; Kosmas Tsakiridis; Andreas Mpakas; Nikolaos Machairiotis; Nikolaos Katsikogiannis; Ioanna Kougioumtzi; Nikolaos Courcoutsakis; Konstantinos Zarogoulidis
Journal:  J Thorac Dis       Date:  2013-09       Impact factor: 2.895

8.  National Lung Screening Trial findings by age: Medicare-eligible versus under-65 population.

Authors:  Paul F Pinsky; David S Gierada; William Hocking; Edward F Patz; Barnett S Kramer
Journal:  Ann Intern Med       Date:  2014-11-04       Impact factor: 25.391

9.  [Effect of Thoracic Surgeons on Lung Cancer Patients' Survival].

Authors:  Ning Li; Fengwei Tan; Bin Qiu; Jiagen Li; Jun Zhao; Yushun Gao; Dali Wang; Yousheng Mao; Qi Xue; Juwei Mu; Shugeng Gao; Jie He
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2018-02-20

10.  Influences of Psychological Intervention on Negative Emotion, Cancer-Related Fatigue and Level of Hope in Lung Cancer Chemotherapy Patients Based on the PERMA Framework.

Authors:  Min Tu; Fan Wang; Sanying Shen; Hui Wang; Jing Feng
Journal:  Iran J Public Health       Date:  2021-04       Impact factor: 1.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.